LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between Incyte Corporation Experimental Station, Route 141 & Henry Clay Road Wilmington, Delaware andLicense, Development and Commercialization Agreement • March 5th, 2010 • Incyte Corp • Services-commercial physical & biological research
THIS LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (the “Agreement”) is entered into as of the 18th day of December, 2009 (“Effective Date”), by and between Incyte Corporation, a Delaware corporation having an office at Experimental Station, Route 141 & Henry Clay Road, Wilmington, Delaware (“Incyte”), and Eli Lilly and Company, an Indiana corporation having an office at Lilly Corporate Center, Indianapolis, Indiana 46285 (“Lilly”).
SIXTH AMENDMENT OF LEASELease • March 5th, 2010 • Incyte Corp • Services-commercial physical & biological research
This SIXTH AMENDMENT OF LEASE made this 15th day of December, 2009 by and between E. I. DU PONT DE NEMOURS AND COMPANY (hereinafter “LANDLORD”) and INCYTE CORPORATION (hereinafter “TENANT”).
Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission. COLLABORATION AND LICENSE AGREEMENT by and between Incyte Corporation Experimental Station, Route 141 &...Collaboration and License Agreement • March 5th, 2010 • Incyte Corp • Services-commercial physical & biological research
THIS COLLABORATION AND LICENSE AGREEMENT (the “Agreement”) is entered into as of the 24th day of November, 2009 (the “Effective Date”), by and between Incyte Corporation, a Delaware corporation having an office at Experimental Station, Route 141 & Henry Clay Road, Wilmington, Delaware (“Incyte”), and Novartis International Pharmaceutical Ltd., a limited company organized under the laws of Bermuda having an office at 131 Front Street, Hamilton, Bermuda HM 12 (“Novartis”).
